Online / Physical Event

7th International Conference on

Tissue Science

Theme: Exploring the Future Directions and Frontiers in Tissue science

Event Date & Time

Event Location

Amsterdam, Netherlands

Program Abstract Registration Awards 2020

18 years of lifescience communication

442039666807

Performers / Professionals From Around The Globe

Conference Speaker

VALERIY-D-PERMINOV

Moscow Central Aerohydrodynamic Institute
Russia

Conference Speaker

ROBERT BOWEN

West Virginia University
USA

Conference Speaker

Miras Mugazov

Karaganda State Medical Univeristy
Kazakhstan

Conference Speaker

Haamid Bashir

Govt Medical College India
India

Conference Speaker

Eldar Aliyev

Central Oilworkers Hospital
Azerbaijan

Conference Speaker

Yogini Patel

Global Hospital & Research Centre
India

Conference Speaker

M. Ahmadzadeh Raji

University of Tehran
Iran

Conference Speaker

Saadia Ijaz

University of the Punjab
Pakistan

Conference Speaker

Piyathip Setthawong

Chulalongkorn University
Thailand

Conference Speaker

Marina Pruidze

Agricultural University
Georgia

Conference Speaker

Maritsa Kurashvili

Agricultural University
Georgia

Conference Speaker

Gia Khatisashvili

Agricultural University
Georgia

Tracks & Key Topics

Tissue Science 2021

About Conference

We are glad to welcome all the participants to  7th International Conference on Tissue science schedule on May 24-25,2021. The conference Theme: "Exploring the Future directions and Frontiers in Tissuescience" that  focuses to share novel approaches related to biotechnology and exploring the challenges concerning excellence in research and advancements, we are pleased to invite all Biotechnologists, Professors, Researchersscientists, Business Giants, CEOs, COOs, Directors, Vice Presidents, Co-directors, Managing Directors, Industry Safety Officers, Environmental & Plant Scientists, Post Doctorate Fellows, Vendors of Consumer Products/ Managers, Pharmaceutical Scientists, Students from the Biotechnology and its allied areas.

This International Tissue science Conferences proceedings include symposiums and workshops, keynote speeches, plenary talks, poster sessions and panel discussion on latest research developments in the field of Science.

EuroSciCon is the longest running independent life science events company with a predominantly academic client base. Our multi professional approach creates a unique experience that cannot be found with a specialist society or commercially.

Market Analysis

Industry Insights

The global biotechnology market size was estimated at USD 369.62 billion in 2016. Presence of room for partnerships in the sector is expected to drive significant progress in the industry. The companies are focusing on the development of novel techniques and their implementation by collaborating with the other participants. Organizations such as the DBT (Department of Biotechnology) together with government funded institutions and other autonomous organizations representing the biotechnology sector promote funding to support R&D and new product development endeavors.

Rise in demand for these therapeutics and diagnostic solutions on principles of red biotechnology, DNA sequencing, and recombinant technology is anticipated to fuel growth. Increasing prevalence of diseases such as hepatitis B, cancer, and other orphan disorders is expected to fuel demand in this space.

Rise in the demand for food and agricultural products including sugarcane, rice, beans, and wheat owing to the growing population base in U.S., China, and India is expected to raise the importance of these products. In addition, factors such as shortage of water, low yield of crops, pest attacks, and limited availability of agricultural land are encouraging researchers to engage in extensive R&D.

Decreasing prices of DNA sequencing is expected to serve this sector as a high impact rendering growth driver. It is expected to encourage researchers and manufacturers to increase R&D initiatives targeted at understanding genetic variations and developing therapeutic solutions for chronic diseases with large global prevalence such as cardiovascular diseases, diabetes, and cancer.

The optimization of sequencers and their software, as well as the involvement of governments and collaborations between these companies and medical specialists, will be of utmost importance for the success of DNA-sequencing technology.

Application Insights

Health associated applications accounted for the largest share as a result of the higher use of associated products in healthcare industry. Growing prevalence of chronic diseases heightening the demand for new drug development is one of the key factors accounting for the aforementioned conclusion. Moreover, growing demand for personalized medicine and biosimilars is also expected to drive segment growth during the forecast period.

Bioinformatics is expected to witness the fastest growth in the coming years as a consequence of substantial developments in this field. Substantial developments include algorithm designing for efficient storage and management of genomic and proteomic data generated through the studies carried out on plant, animal or human genomes.
Technology Insights

Nanobiotechnology dominated in terms of revenue share in 2016. Nanobiotechnology finds major application in drug delivery therapies for chronic disorders such as cancer. It involves the development of nanoparticle based chemotherapeutic drugs, gold nanoparticles, and quantum dots for molecular diagnosis and nanobiosensors which help in optical imaging and drug delivery. Growing R&D carried out in various companies in discovering new avenues such as microfabricated systems and devices used in the treatment of several acute ailments is a key driving factor of this segment.

Bioinformatics is expected to witness the fastest growth in the coming years. Uptake of cloud based solutions which effectively and robustly manage the parallelization and distribution of input data and user code on many computer nodes is attributive for estimated growth in the bioinformatics based methods. The introduction of cloud computing environment for processing NGS generated data has played a great role as a driving force in current scenario.

Regional Insights

North America dominated the overall market in terms of revenue in 2016 at 44.15%. Presence of high R&D investments pertaining to new drug discovery and development are some factors attributing to its large share. The U.S. spends more per capita on healthcare than other countries and has a high growth rate amongst other countries. According to the estimates published by OECD Health Statistics in 2014, it has been estimated that in 2012, U.S. spent nearly 16.9% of its GDP towards healthcare expenditure, which is the highest. The aforementioned fact supports the estimated share of biotechnology market.

Asia Pacific on the other hand, is expected to gain market share during the forecast period owing to the presence of patient awareness, rapidly improving healthcare infrastructure, and rising healthcare expenditure levels in the emerging markets. These markets include the developing economies of China and India.

Competitive Insights

The industry is fragmented in nature. This market encompasses several small and emerging players along with well-established major players. Some key players in the market are Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd, Pfizer, Merck & Co., and Sanofi. Large firms are targeting small firms with an operating strategy of acquisition in order to sustain position in the market. For instance, in July 2017, Sanofi announced to acquire Protein Sciences, a U.S. based company which deals with the R&D of vaccines, in the third quarter of this year. This acquisition by the company aimed at an addition of recombinant based influenza vaccine to its product portfolio.

Segments Covered in the Report

This report forecasts revenue growth at regional & country level and provides an analysis on the latest trends and opportunities in each of the sub-segments from 2014 to 2025. For the purpose of this report, Grand View Research has segmented the biotechnology market on the basis of technology, application, and regions:

 

Sessions & Tracks

Track 01: Tissue Engineering:

This interdisciplinary engineering has attracted much attention as a new therapeutic means that may overcome the drawbacks involved in the current artificial organs and organ transplantation that have been also aiming at replacing lost or severely damaged tissues or organs. Tissue engineering and regenerative medicine is an exciting research area that aims at regenerative alternatives to harvested tissues for organ transplantation with soft tissues. Although significant progress has been made in the tissue engineering field, many challenges remain and further development in this area will require on-going interactions and collaborations among the scientists from multiple disciplines, and in partnership with the regulatory and the funding agencies. As a result of the medical and market potential, there is significant academic and corporate interest in this technology.

Track 02: Tissue Repair and Regeneration

Deregulation of normal tissue repair has dramatic consequences for life quality and survival of patients. Together, insufficient healing (chronic wounds) and excessive repair after injury (scarring/fibrosis) cause healthcare costs reaching tens of billions of dollars per year in the US alone. Chronic and fibrotic healing occurs when the body’s own repair capacity is either impaired or overwhelmed. One approach in regenerative medicine is to replace injured, diseased or aged tissues with functional tissue equivalents. This approach is challenged by adverse host reactions that are part of the body repair program, e.g., immune, inflammatory, and fibrotic responses.

 

Track 03: Plant Tissue Culture and Plant Biotechnology

Plant Genetics qualities assume a key job in the cutting edge hypotheses of heredity. There are different present day methods to grow hereditarily change plants, hereditarily built harvests. Epigenetics is the trading between the heredity and the earth through atomic components (DNA methylation, quality quieting, fluorescent in situ hybridization.

 

Track 04: Clinical Medicine and Scaffolds

 

Clinical medicine relates to medicine field that deals mainly with the study and practice of medicine based on the direct examination of the patient. In clinical medicine, medical practitioners assess patients in order to diagnose, treat, and prevent disease.


Scaffolds:

 

Scaffolds are one of the three most important essentials constituting the basic concept of Regenerative Medicine, and are included in the core technology of Regenerative Medicine. Every day thousands of surgical procedures are done to replace or repair tissue that has been damaged through disease or trauma. The developing field of tissue engineering (TE) aims to regenerate damaged tissues by combining cells from the body with highly porous scaffold biomaterials, which act as templates for tissue regeneration, to guide the growth of new tissue.

Track 05: Bio Banking

Biobanks play a crucial role in biomedical research. The wide array of bio specimens (including blood, saliva, plasma, and purified DNA) maintained in biobanks can be described as libraries of the human organism. They are carefully characterized to determine the general and unique features of the continuous cell line and the absence or presence of contaminants, therefore establishing a fundamental understanding about the raw material from which the biological product is being derived and maintained. Biobanks catalogue specimens using genetic and other traits, such as age, gender, blood type, and ethnicity.

Track 06: Animal Tissue Culture

Animal cell culture is a significant tool for biological research. The importance of cell culture technology in biological science was realized a long time ago. Earlier dedifferentiation based experiments of cells due to selective overgrowth of fibroblasts resulted in the enhancement of culture techniques. Animal cell culture involves isolation of cells from a tissue before establishing a culture in a suitable artificial environment.

  • Drug screening and development.
  • Mutagenesis and carcinogenesis.
  • Normal physiology and biochemistry of cells.
  • Potential effects of drugs and toxic compounds on the cells.

 

Track 07: Regenerative Rehabilitation

Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human or animal cells, tissues or organs to restore or establish normal function".

 Regenerative medicine also includes the possibility of growing tissues and organs in the laboratory and implanting them when the body cannot heal itself. When the cell source for a regenerated organ is derived from the patient's own tissue or cells, the challenge of organ transplant rejection via immunological mismatch is circumvented. 

Track 08: Biomaterials & Bioengineering

 

Biomaterials are being utilized for the social insurance applications from old circumstances. In any case, consequent development has made them more flexible and has expanded their utility. Biomaterials have reformed the territories like bioengineering and tissue designing for the advancement of novel methodologies to battle perilous infections. Together with biomaterials, immature microorganism innovation is additionally being utilized to enhance the current human services offices.

 

Track 09: Genetics & Genomics:

Genetics could be a branch of biology involved with the study of genes, genetic variation, and heredity in organisms. Although heredity had been discovered for millennia, Gregory botanist, a soul and Augustinian religious operating within the nineteenth century, was the primary to check biology scientifically. Botanist studied "trait inheritance", patterns within the manner traits area unit handed down from oldsters to offspring. Genetics is associate knowledge base field of biology that specializes in the structure, function, evolution, mapping, and piece of writing of genomes. A ordination is associate organism's complete set of polymer, as well as all of its genes. In distinction to biology, this refers to the study of individual genes and their roles in inheritance, genetics aims at the collective characterization associated quantification of all of an organism’s genes, their interrelations and influence on the organism.

Track10: Histology And Histopathology :

Histology conjointly called anatomy or microanatomy is that the branch of biology that studies the anatomy of biological tissues. Microscopic anatomy is that the microscopic counterpart to anatomy, that appearance at larger structures visible whiles not a magnifier. Though one might divide anatomy into organology, the study of organs, histology, the study of tissues, and microscopic anatomy, the study of cells, trendy usage places these topics beneath the sector of microscopic anatomy. Histopathology refers to the microscopic examination of tissue so as to review the manifestations of illness.

 

Track 11: Biomedical Engineering

Biomedical engineering approaches to help aid in the detection and treatment of tropical diseases such as dengue, malaria, cholera, schistosomiasis, lymphatic filariasis, ebola, leprosy, leishmaniasis, and American trypanosomiasis (Chagas). Many different forms of non-invasive approaches such as ultrasound, echocardiography and electrocardiography, bioelectrical impedance, optical detection, simplified and rapid serological tests such as lab-on-chip and micro-/nano-fluidic platforms and medical support systems such as artificial intelligence clinical support systems are included in Biomedical Engineering Techniques.

Track 12: Artificial Organs

A Bioartificial organ is a designed device or tissue which is consolidated into human body to supplant a characteristic organ .It joins biomaterials and natural cells for completely substitution of patient disappointment organs. Example of bioartificial organ are bioartificial kidney device, joining biomaterials and kidney epithelial cells for enhanced blood detoxification, bioartificial pancreas device, consolidating exemplification of pancreatic cells for treatment of diabetes, bioartificial lungs for considering lung recovery.

·         Prosthetic Cardiac Valves

·         Artificial Lung (oxygenator)

·         Bio Artificial Windpipe

·         Artificial Kidney (Dialyser membrane)

 

Track13: Gene therapy

Human cell therapy and gene therapy is the administration of cellular and genetic material to modify or manipulate the expression of a gene product or to alter the biological properties of living cells for therapeutic use. Gene therapy is a technique that modifies a person’s genes to treat or cure disease. Gene therapies can work by several mechanisms: Replacing a disease-causing gene with a healthy copy of the gene, inactivating a disease-causing gene that is not functioning properly, introducing a new or modified gene into the body to help treat a disease.

Track 14: Soft Tissue Replacement

In soft tissue implants, as in other applications that involve engineering, the performance of an implanted device depends upon both the materials used and the design of the device or implant. The initial selection of material should be based on sound materials engineering practice. The final judgment on the suitability of a material depends upon observation of the in-vivo clinical performance of the implant. Such observations may require many years or decades. This requirement of in-vivo observation represents one of the major problems in the selection of appropriate materials for use in the human body.

 

Track 15: Stem Cells and Regenerative Medicine

Recently, cord blood stems cells are developed in the treatment of different diseases, including a broad range of cancers, blood disorders, and genetic diseases. In a cord blood transplant, stem cells are infused in to a patient’s bloodstream for healing and repairing damaged cells and tissue. In a successful transplant, new healthy immune system has been created. The natural power and purity of newborn's cord blood are responsible for healthy development during gestation. Cord blood applications have developed beyond transplant medicine into the areas of regenerative medicine including brain injuries, autism, Cardiac Problems, and Autoimmune Deficiencies. The latest research in routine transplantation of cord blood are reviewed followed by the critical role of cord blood stem cells in regenerative medicine research and novel approaches using cord blood as a source of whole blood for transfusion.

Track 16: Veterinary and comparative sciences

Veterinary Experimental and Diagnostic Pathology publishes high-quality basic and applied research that contributes substantially to our understanding of the pathogenesis of disease, its molecular, functional, and morphologic manifestations, and the development and application of novel techniques and biomarkers that enhance our ability to understand, detect, diagnose, and monitor disease in animals.

Track17: Rejuvenation

Rejuvenation is a medical discipline focused on the practical reversal of the aging process. Rejuvenation is distinct from life extension. Life extension strategies often study the causes of aging and try to oppose those causes in order to slow aging. Rejuvenation is the reversal of aging and thus requires a different strategy, namely repair of the damage that is associated with aging or replacement of damaged tissue with new tissue. Rejuvenation can be a means of life extension, but most life extension strategies do not involve rejuvenation.

  • Cell immortalization and senescence
  • Pluripotent stem cells
  • DNA damage
  • Gene targeting

 

Track 18: Biochips & Tissue chips

Biochips refer to the complete fundamental functional unit, capable of performing multi biochemical tasks simultaneously. Tissue chips on the other hand are similar miniaturized units that can replace a tissue or some part of it, enabling the organ to work normally. Both biochips & tissue chips have been elemental in tissue engineering technology and have proven to be of utmost importance in the same arena. DNA microarray also called as biochip in simple terms consists of a two dimensional grid system where upon sensors or solid flat substrates are incorporated. These solid substrates can be either positively charged just like silicon or glass or can also be consisting of integrated circuitry units that perform best in signal transduction studies. These sorts of microarrays have application in micromechanical studies.

 

Track 19:- Stem cells and Clinical trials

Stem cell transplant is treatment in some types of cancers like leukemia, multiple myeloma, or some types of lymphoma. Stem cell transplantation is the procedure that restores blood-forming stem cells in patients who have had theirs destroyed by the very high doses of chemotherapy or radiation therapy that are used to treat certain cancers.

Clinical trials with Stem Cells

Stem cell treatments and clinical trials have been going on for over 40 years; however we are still in the initial stages of stem cell therapy being utilized as an effective alternative treatment method to traditional pharmaceutical based treatments.

 

Track 20: Grafts in Tissue Engineering

Grafting is a surgical procedure to move tissue from one site to another on the body, or from another creature, without bringing its own blood supply with it. Instead, a new blood supply grows in after it is placed. Different types of grafting contains  skin grafting, bone grafting, vascular grafting and ligament repair. Skin grafting is most common used grafting technique. Wounds, burns and scars have been dealt with this efficiently. Bone transplantation is a bit difficult but well-known process to replace damaged bones. In Recent years cardiovascular disease are being combatted with the development of a tissue-engineered vascular graft (TEVG).

 

  • Wound healing and repair
  • Cartilage replacement
  • Bone replacement
  • Hip replacement

 

 

 

 

Media Partners/Collaborator

A huge thanks to all our amazing partners. We couldn’t have a conference without you!

Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker
Conference Speaker

Sponsors/Exhibitors

A huge thanks to all our amazing partners. We couldn’t have a conference without you!